| Dr Issa Y Al Rabadi, MD | |
|
900 E Broadway Ave, Bismarck, ND 58501-4520 | |
| (701) 530-7000 | |
| Not Available |
| Full Name | Dr Issa Y Al Rabadi |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 15 Years |
| Location | 900 E Broadway Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104249507 | NPI | - | NPPES |
| 1464593 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 13746 (North Dakota) | Secondary |
| 207Q00000X | Family Medicine | 13746 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Bismarck | Bismarck, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Bismarck | 9739098575 | 448 |
News Archive
Results of a Phase III study presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival (OS) compared with Treatment of Physician's Choice (TPC) in heavily pre-treated metastatic breast cancer patients.
An inquiry by the Senate Finance Committee has found that the nation's three largest home-health companies tailored the care they provided to Medicare patients to maximize their reimbursements from the federal program.
Anthem Blue Cross and Blue Shield and New Haven Community Medical Group announced today that the two organizations have partnered under a patient-centered care agreement that will create an accountable care model to help ensure Anthem members' access to quality health care that is focused on improved outcomes and lower costs.
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
› Verified 8 days ago
| Entity Name | St Alexius Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205868429 PECOS PAC ID: 8426960865 Enrollment ID: O20031104000146 |
News Archive
Results of a Phase III study presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival (OS) compared with Treatment of Physician's Choice (TPC) in heavily pre-treated metastatic breast cancer patients.
An inquiry by the Senate Finance Committee has found that the nation's three largest home-health companies tailored the care they provided to Medicare patients to maximize their reimbursements from the federal program.
Anthem Blue Cross and Blue Shield and New Haven Community Medical Group announced today that the two organizations have partnered under a patient-centered care agreement that will create an accountable care model to help ensure Anthem members' access to quality health care that is focused on improved outcomes and lower costs.
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
› Verified 8 days ago
| Entity Name | Sanford Bismarck |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811941172 PECOS PAC ID: 9739098575 Enrollment ID: O20031105000403 |
News Archive
Results of a Phase III study presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival (OS) compared with Treatment of Physician's Choice (TPC) in heavily pre-treated metastatic breast cancer patients.
An inquiry by the Senate Finance Committee has found that the nation's three largest home-health companies tailored the care they provided to Medicare patients to maximize their reimbursements from the federal program.
Anthem Blue Cross and Blue Shield and New Haven Community Medical Group announced today that the two organizations have partnered under a patient-centered care agreement that will create an accountable care model to help ensure Anthem members' access to quality health care that is focused on improved outcomes and lower costs.
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Issa Y Al Rabadi, MD Po Box 997, Bismarck, ND 58502-0997 Ph: (701) 530-7000 | Dr Issa Y Al Rabadi, MD 900 E Broadway Ave, Bismarck, ND 58501-4520 Ph: (701) 530-7000 |
News Archive
Results of a Phase III study presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's eribulin mesylate significantly improved median overall survival (OS) compared with Treatment of Physician's Choice (TPC) in heavily pre-treated metastatic breast cancer patients.
An inquiry by the Senate Finance Committee has found that the nation's three largest home-health companies tailored the care they provided to Medicare patients to maximize their reimbursements from the federal program.
Anthem Blue Cross and Blue Shield and New Haven Community Medical Group announced today that the two organizations have partnered under a patient-centered care agreement that will create an accountable care model to help ensure Anthem members' access to quality health care that is focused on improved outcomes and lower costs.
Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
› Verified 8 days ago
Gary Robert Betting, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 E Broadway, Center For Family Medicine, Bismarck, ND 58501 Phone: 701-751-9500 Fax: 701-751-9508 | |
James B Bossort, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-5709 | |
Haily Datz, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-751-9500 Fax: 701-751-9508 | |
Monika Pothamsetti, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 701 E Rosser Ave, Bismarck, ND 58501 Phone: 701-751-9500 | |
Olimpia Rauta, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 Fax: 701-323-8305 | |
Dr. Jeremiah Jon Penn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St., Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6422 | |
Dr. Todd W Schaffer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3318 N 14th St, Bismarck, ND 58503 Phone: 701-323-8300 Fax: 701-323-8305 |